StockSelector.com
  Research, Select, & Monitor Friday, November 24, 2017 2:36:29 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Amdocs, Ltd.$64.64($.14)(.22%)

  Quote | Ranking | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

 Amdocs Limited Reports Record Quarterly Revenue of $927M
   Tuesday, November 10, 2015 4:01:03 PM ET

Expects Fiscal 2016 Revenue Growth of 2.0-6.0% YoY in Constant Currency and 1.0-5.0% YoY as Reported

Quarterly Cash Dividend to be Raised From $0.17 to $0.195 Per Share, Subject to Shareholder Approval at Annual Meeting, February 2016

Key highlights:

-- Fourth fiscal quarter revenue of $927 million, within the $915-$955 million guidance range. Revenue was slightly above the midpoint of expectations, excluding foreign currency movements. Foreign currency movements negatively affected revenue by approximately $9 million relative to the third quarter of fiscal 2015

-- Fourth fiscal quarter diluted non-GAAP EPS of $0.84, in line with the high-end of the $0.79-$0.85 guidance range, excluding amortization of purchased intangible assets and other acquisition-related costs, nonrecurring restructuring charges associated with the acquisition of the Comverse BSS assets, and equity-based compensation expense, net of related tax effects

-- Fourth fiscal quarter non-GAAP operating income of $157 million; non-GAAP operating margin of 16.9%; GAAP operating income of $110 million

-- Diluted GAAP EPS of $0.59 for the fourth fiscal quarter, in line with the high-end of the $0.49-$0.59 guidance range

-- Strong free cash flow of $180 million for the fourth fiscal quarter

-- Repurchased $182 million of ordinary shares during the fourth fiscal quarter

-- Twelve-month backlog of $3.08 billion at the end of the fourth fiscal quarter, up $70 million from the end of the third quarter of fiscal 2015

-- The board of directors approved a $0.17 per share quarterly cash dividend to be paid on January 15, 2016, and, subject to shareholders’ approval at the February 2016 annual general meeting of shareholders, an increase in the quarterly cash dividend to $0.195 per share, anticipated to be paid in April 2016

-- First quarter fiscal 2016 guidance: Expected revenue of approximately $905-$945 million. Expected diluted non-GAAP EPS of approximately $0.82-$0.88, excluding amortization of purchased intangible assets and other acquisition-related costs, and approximately $0.09-$0.10 per share of equity-based compensation expense, net of related tax effects. Expected diluted GAAP EPS of approximately $0.59-$0.67

-- Fiscal 2016 guidance: Expected revenue growth of 2.0-6.0% in constant currency and 1.0-5.0% as reported, including a negative impact from foreign currency movements of approximately 1%, and non-GAAP diluted earnings per share growth of roughly 3.5-7.5%, including the impact of anticipated share repurchase activity over the course of the fiscal year

Amdocs Limited (DOX ) today reported that for its fourth fiscal quarter ended September 30, 2015, revenue was $926.8 million, up 2.1% sequentially from the third fiscal quarter of 2015 and up 2.9% as compared to last year’s fourth fiscal quarter. Fourth fiscal quarter revenue includes a negative impact from foreign currency movements of approximately $9 million relative to the third quarter of fiscal 2015. Net income on a non-GAAP basis was $130.4 million, or $0.84 per diluted share, compared to non-GAAP net income of $124.3 million, or $0.78 per diluted share, in the fourth quarter of fiscal 2014. Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition-related costs, nonrecurring restructuring charges associated with the acquisition of the Comverse BSS assets and equity-based compensation expenses of $39.2 million, net of related tax effects, in the fourth quarter of fiscal 2015 and excludes such amortization and other acquisition-related costs, changes in fair value of certain acquisition-related liabilities and equity-based compensation expenses of $23.8 million, net of related tax effects, in the fourth quarter of fiscal 2014. The Company’s GAAP net income for the fourth quarter of fiscal 2015 was $91.1 million, or $0.59 per diluted share, compared to GAAP net income of $100.5 million, or $0.63 per diluted share, in the prior fiscal year’s fourth quarter.

"We concluded fiscal 2015 with another solid quarter. Revenue was slightly above the mid-point of our expectations after adjusting for the negative impact of foreign currencies, and the quarter included another record contribution in our Rest-of-World markets where we delivered growth of 27% for the full year. As we previously anticipated, uncertainty resulting from customer consolidation activity continued to impact our performance in North America but we remained focused on providing value to our customers while maintaining strict operational execution across the various dimensions of our business. Additionally, our free cash flow was robust and we delivered on our commitment to accelerate our share repurchase activity in the fourth fiscal quarter. Overall, we grew non-GAAP diluted earnings per share by 7% in fiscal 2015, which is consistent with the high-end of our guidance issued at the start of the year," said Eli Gelman, president and chief executive officer of Amdocs Management Limited.

Gelman continued, "Our win rate was strong across all regions in fiscal 2015 and included several significant new awards in the fourth quarter. We are delighted to announce today that Vodafone UK has selected Amdocs for a major four-year managed BSS/OSS transformation project in support of its enterprise business. Additionally, KT Corporation in Korea has selected Amdocs under a multi-year services agreement for a strategic charging transformation project to consolidate and modernize charging operations across its quad-play lines of business, and Singtel has selected Amdocs for a digital transformation project targeted to deliver a new online care and commerce platform in its key markets of Singapore and Australia. Finally, in North America, we extended our existing managed services arrangement with Bell Canada for five years through 2022 and signed a new agreement with Rogers Communications to service multiple lines of business for three years through 2018."

Gelman concluded, "Looking into fiscal 2016, we expect to deliver non-GAAP earnings per share growth of 3.5% to 7.5%. This outlook takes into consideration many macro and industry specific risks and unknowns, including uncertainties related to AT&T’s discretionary spending plans, although we cannot predict all possible outcomes. Additionally, we are pleased to announce that our Board has approved an increase in the quarterly cash dividend for the third consecutive year to a new rate of $0.195 per share. The decision reaffirms our commitment to enhance long-term shareholder value, and will represent an improvement of nearly 15% over the current dividend rate if approved by shareholders at the annual meeting in February 2016."

Financial Discussion of Fourth Fiscal Quarter Results

Free cash flow was $180 million for the quarter, comprised of cash flow from operations of $207 million less $27 million in net capital expenditures and other.

Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $3.08 billion at the end of the fourth quarter of fiscal 2015, up $70 million sequentially.

Fiscal Year 2015 Results

For the fiscal year ended September 30, 2015, revenue increased by 2.2% to $3.6 billion. Fiscal 2015 net income on a non-GAAP basis was $529.7 million, or $3.38 per diluted share (excluding amortization of purchased intangible assets and other acquisition-related costs, nonrecurring restructuring charges associated with the acquisition of the Comverse BSS assets, changes in fair value of certain acquisition-related liabilities and equity-based compensation expenses of $83.5 million, net of related tax effects), compared to non-GAAP net income of $509.6 million, or $3.16 per diluted share, in fiscal 2014 (excluding amortization of purchased intangible assets and other acquisition-related costs, changes in fair value of certain acquisition-related liabilities and equity-based compensation expenses of $87.5 million, net of related tax effects). The Company’s GAAP net income in fiscal 2015 was $446.2 million, or $2.85 per diluted share, compared to GAAP net income of $422.1 million, or $2.62 per diluted share, in fiscal 2014.

Financial Outlook

Amdocs expects that revenue for the first quarter of fiscal 2016 will be approximately $905-$945 million. This outlook takes into consideration our expectations regarding macro and industry specific risks and various uncertainties resulting from current and potential customer consolidation activity in North America. However, we remind you that we cannot predict all possible outcomes.

Diluted earnings per share on a non-GAAP basis for the first fiscal quarter is expected to be $0.82-$0.88, excluding amortization of purchased intangible assets and other acquisition-related costs, and approximately $0.09-$0.10 per share of equity-based compensation expense, net of related tax effects. Amdocs estimates GAAP diluted earnings per share for the first fiscal quarter will be $0.59-$0.67.

Quarterly Cash Dividend Program

On November 10, 2015, the Board approved the Company’s next quarterly cash dividend payment of $0.17 per share and set December 31, 2015 as the record date for determining the shareholders entitled to receive the dividend, which will be payable on January 15, 2016. The Board also approved an increase in the Company’s quarterly cash dividend payment to $0.195 per share, which is anticipated to be paid in April 2016, provided that the increase is approved by shareholders at the February 2016 annual general meeting of shareholders.

Conference Call Details

Amdocs will host a conference call on November 10, 2015 at 5:00 p.m. Eastern Time to discuss the Company’s fourth fiscal quarter and fiscal year-end results. To participate, please dial +1 (330) 863-3318, or +1 (855) 870-4313 outside the United States, approximately 15 minutes before the call and enter passcode 48248949. The call will also be carried live on the Internet via the Amdocs website, www.amdocs.com.

Non-GAAP Financial Measures

This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expense, net, non-GAAP income taxes, non-GAAP net income and non-GAAP diluted earnings per share growth. These non-GAAP measures exclude the following items:

-- amortization of purchased intangible assets and other acquisition-related costs;

-- changes in fair value of certain acquisition-related liabilities;

-- nonrecurring restructuring charges associated with the Comverse acquisition;

-- equity-based compensation expense; and

-- tax effects related to the above.

These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.

Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expense, net, non-GAAP income taxes, non-GAAP net income and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs, nonrecurring restructuring charges associated with the acquisition of the Comverse BSS assets, changes in fair value of certain acquisition-related liabilities, equity-based compensation expense and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, interest and other expense, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

About Amdocs

Amdocs is the market-leader in customer experience software solutions and services for the world’s largest communications, entertainment and media service providers. Our portfolio powers The New World of Customer Experience(TM), where a wide array of innovative and personalized services are delivered seamlessly to end users, regardless of device or network.

For more than 30 years, Amdocs solutions, which include BSS, OSS, network control and optimization, coupled with our professional and managed services, have accelerated business value for our customers by streamlining complex operating environments, reducing costs and speeding time to market for new products and services.

Amdocs and our more than 24,000 employees serve customers in over 90 countries. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $3.6 billion in fiscal 2015.

Amdocs: Embrace Challenge, Experience Success.

For more information, visit Amdocs at www.amdocs.com.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company’s filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2014 filed on December 8, 2014 and our Forms 6-K furnished for the first quarter of fiscal 2015 on February 9, 2015, for the second quarter of fiscal 2015 on May 11, 2015 and for the third quarter of fiscal 2015 on August 10, 2015.

AMDOCS LIMITED
Consolidated Statements of Income
(in thousands, except per share data)
                                                      Three months ended  Fiscal year ended
                                                      September 30,       September 30,
                                                      2015      2014      2015       2014
Revenue                                               $926,776  $900,261  $3,643,538 $3,563,637
Operating expenses:
Cost of revenue                                       603,105   581,601   2,349,488  2,306,892
Research and development                              65,900    67,604    254,944    257,896
Selling, general and administrative                   111,191   110,056   440,085    445,134
Amortization of purchased intangible assets and other 23,880    14,893    70,073     58,067
Restructuring charges                                 13,000    --        13,000     --
                                                      817,076   774,154   3,127,590  3,067,989
Operating income                                      109,700   126,107   515,948    495,648
Interest and other expense, net                       1,375     2,038     2,544      6,098
Income before income taxes                            108,325   124,069   513,404    489,550
Income taxes                                          17,195    23,566    67,241     67,428
Net income                                            $91,130   $100,503  $446,163   $422,122
Basic earnings per share                              $0.60     $0.64     $2.89      $2.65
Diluted earnings per share                            $0.59     $0.63     $2.85      $2.62
Basic weighted average number of shares outstanding   152,601   157,346   154,423    159,012
Diluted weighted average number of shares outstanding 155,201   159,667   156,809    161,366
Cash dividends declared per share                     $0.170    $0.155    $0.665     $0.595
AMDOCS LIMITED
Selected Financial Metrics
(in thousands, except per share data)
                                                      Three months ended  Fiscal year ended
                                                      September 30,       September 30,
                                                      2015      2014      2015       2014
Revenue                                               $926,776  $900,261  $3,643,538 $3,563,637
Non-GAAP operating income                             156,917   151,558   618,675    598,293
Non-GAAP net income                                   130,353   124,269   529,700    509,602
Non-GAAP diluted earnings per share                   $0.84     $0.78     $3.38      $3.16
Diluted weighted average number of shares outstanding 155,201   159,667   156,809    161,366
AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(in thousands)
                                                       Three months ended
                                                       September 30, 2015
                                                                 Reconciliation items
                                                       GAAP      Amortization of  Equity based Restructuring       Tax effect Non-GAAP
                                                                 purchased        compensation charges
                                                                 intangible       expense
                                                                 assets and other
Operating expenses:
Cost of revenue                                        $603,105  $ --             $(3,854)     $ --                $ --       $599,251
Research and development                               65,900    --               (830)        --                  --         65,070
Selling, general and administrative                    111,191   --               (5,653)      --                  --         105,538
Amortization of purchased intangible assets and other  23,880    (23,880)         --           --                  --         --
Restructuring charges                                  13,000    --               --           (13,000)            --         --
Total operating expenses                               817,076   (23,880)         (10,337)     (13,000)            --         769,859
Operating income                                       109,700   23,880           10,337       13,000              --         156,917
Income taxes                                           17,195    --               --           --                  7,994      25,189
Net income                                             $91,130   $23,880          $10,337      $13,000             $(7,994)   $130,353
                                                       Three months ended
                                                       September 30, 2014
                                                                 Reconciliation items
                                                       GAAP      Amortization of  Equity based Changes in fair     Tax effect Non-GAAP
                                                                 purchased        compensation value of certain
                                                                 intangible       expense      acquisition-
                                                                 assets and other              related liabilities
Operating expenses:
Cost of revenue                                        $581,601  $ --             $(4,276)     $ --                $ --       $577,325
Research and development                               67,604    --               (914)        --                  --         66,690
Selling, general and administrative                    110,056   --               (5,368)      --                  --         104,688
Amortization of  purchased intangible assets and other 14,893    (14,893)         --           --                  --         --
Total operating expenses                               774,154   (14,893)         (10,558)     --                  --         748,703
Operating income                                       126,107   14,893           10,558       --                  --         151,558
Interest and other expense, net                        2,038     --               --           (3,921)             --         (1,883)
Income taxes                                           23,566    --               --           --                  5,606      29,172
Net income                                             $100,503  $14,893          $10,558      $3,921              $(5,606)   $124,269
AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(in thousands)
                                                      Fiscal year ended
                                                      September 30, 2015
                                                                 Reconciliation items
                                                      GAAP       Amortization of  Equity based Restructuring Changes in fair     Tax effect Non-GAAP
                                                                 purchased        compensation charges       value of certain
                                                                 intangible       expense                    acquisition-
                                                                 assets and other                            related liabilities
Operating expenses:
Cost of revenue                                       $2,349,488 $ --             $(15,621)    $ --          $24,906             $ --       $2,358,773
Research and development                              254,944    --               (3,400)      --            --                  --         251,544
Selling, general and administrative                   440,085    --               (25,539)     --            --                  --         414,546
Amortization of purchased intangible assets and other 70,073     (70,073)         --           --            --                  --         --
Restructuring charges                                 13,000     --               --           (13,000)      --                  --         --
Total operating expenses                              3,127,590  (70,073)         (44,560)     (13,000)      24,906              --         3,024,863
Operating income                                      515,948    70,073           44,560       13,000        (24,906)            --         618,675
Interest and other expense, net                       2,544      --               --           --            3,921               --         6,465
Income taxes                                          67,241     --               --           --            --                  15,269     82,510
Net income                                            $446,163   $70,073          $44,560      $13,000       $(28,827)           $(15,269)  $529,700
                                                      Fiscal year ended
                                                      September 30, 2014
                                                                 Reconciliation items
                                                      GAAP       Amortization of  Equity based Changes in fair     Tax effect Non-GAAP
                                                                 purchased        compensation value of certain
                                                                 intangible       expense      acquisition-
                                                                 assets and other              related liabilities
Operating expenses:
Cost of revenue                                       $2,306,892 $ --             $(17,496)    $ --                $ --       $2,289,396
Research and development                              257,896    --               (3,599)      --                  --         254,297
Selling, general and administrative                   445,134    --               (23,483)     --                  --         421,651
Amortization of purchased intangible assets and other 58,067     (58,067)         --           --                  --         --
Total operating expenses                              3,067,989  (58,067)         (44,578)     --                  --         2,965,344
Operating income                                      495,648    58,067           44,578       --                  --         598,293
Interest and other expense, net                       6,098      --               --           (3,921)             --         2,177
Income taxes                                          67,428     --               --           --                  19,086     86,514
Net income                                            $422,122   $58,067          $44,578      $3,921              $(19,086)  $509,602
AMDOCS LIMITED
Condensed Consolidated Balance Sheets
(in thousands)
                                                                                   As of
                                                                                   September 30, September 30,
                                                                                   2015          2014
ASSETS
Current assets
Cash, cash equivalents and short-term interest-bearing investments                 $1,354,012    $1,424,465
Accounts receivable, net, including unbilled of $80,197 and $134,523, respectively 714,784       715,837
Deferred income taxes and taxes receivable                                         193,207       148,346
Prepaid expenses and other current assets                                          116,159       135,326
Total current assets                                                               2,378,162     2,423,974
Equipment and leasehold improvements, net                                          309,320       288,956
Goodwill and other intangible assets, net                                          2,301,610     2,106,452
Other noncurrent assets                                                            335,560       365,895
Total assets                                                                       $5,324,652    $5,185,277
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Accounts payable, accruals and other                                               $871,555      $785,548
Short-term financing arrangements                                                  220,000       210,000
Deferred revenue                                                                   198,470       156,743
Deferred income taxes and taxes payable                                            73,478        48,456
Total current liabilities                                                          1,363,503     1,200,747
Other noncurrent liabilities                                                       554,307       588,694
Shareholders’ equity                                                               3,406,842     3,395,836
Total liabilities and shareholders’ equity                                         $5,324,652    $5,185,277
AMDOCS LIMITED
Consolidated Statements of Cash Flows
(in thousands)
                                                                           Fiscal year ended September 30,
                                                                           2015            2014
Cash Flow from Operating Activities:
Net income                                                                 $446,163        $422,122
Reconciliation of net income to net cash provided by operating activities:
Depreciation and amortization                                              174,795         162,772
Equity-based compensation expense                                          44,560          44,578
Deferred income taxes                                                      (26,887)        (6,510)
Excess tax benefit from equity-based compensation                          (5,949)         (3,925)
Loss from short-term interest-bearing investments                          476             1,023
Net changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable                                                        39,829          5,540
Prepaid expenses and other current assets                                  22,690          (1,769)
Other noncurrent assets                                                    7,406           7,434
Accounts payable, accrued expenses and accrued personnel                   63,894          73,949
Deferred revenue                                                           2,434           (1,967)
Income taxes payable                                                       23,474          1,106
Other noncurrent liabilities                                               (20,263)        4,905
Net cash provided by operating activities                                  772,622         709,258
Cash Flow from Investing Activities:
Payments for purchase of equipment and leasehold improvements, net         (120,503)       (111,569)
Proceeds from sale of short-term interest-bearing investments              252,818         379,484
Purchase of short-term interest-bearing investments                        (250,184)       (389,800)
Net cash paid for acquisitions                                             (263,193)       (180,540)
Other                                                                      1,408           3,872
Net cash used in investing activities                                      (379,654)       (298,553)
Cash Flow from Financing Activities:
Borrowings under financing arrangements                                    220,000         210,000
Payments under financing arrangements                                      (210,000)       (200,000)
Repurchase of shares                                                       (454,020)       (372,014)
Proceeds from employee stock options exercised                             78,206          128,125
Payments of dividends                                                      (100,790)       (90,939)
Excess tax benefit from equity-based compensation                          5,949           3,925
Other                                                                      (9)             (725)
Net cash used in financing activities                                      (460,664)       (321,628)
Net (decrease) increase in cash and cash equivalents                       (67,696)        89,077
Cash and cash equivalents at beginning of period                           1,103,269       1,014,192
Cash and cash equivalents at end of period                                 $1,035,573      $1,103,269
AMDOCS LIMITED
Supplementary Information
(in millions)
                         Three months ended
                         September 30, June 30, March 31, December 31, September 30,
                         2015          2015     2015      2014         2014
North America            $626.6        $623.1   $646.7    $659.1       $662.7
Europe                   115.3         102.3    97.6      106.9        105.3
Rest of World            184.9         182.5    158.3     140.3        132.3
Total Revenue            $926.8        $907.9   $902.6    $906.3       $900.3
                         Three months ended
                         September 30, June 30, March 31, December 31, September 30,
                         2015          2015     2015      2014         2014
Managed Services Revenue $466.6        $460.6   $448.8    $467.1       $436.4
                         Three months ended
                         September 30, June 30, March 31, December 31, September 30,
                         2015          2015     2015      2014         2014
Customer Experience
Solutions                $899.4        $883.7   $877.1    $882.4       $871.5
Directory                27.4          24.2     25.5      23.9         28.8
Total Revenue            $926.8        $907.9   $902.6    $906.3       $900.3
                         As of
                         September 30, June 30, March 31, December 31, September 30,
                         2015          2015     2015      2014         2014
12-Month Backlog         $3,080        $3,010   $3,000    $3,030       $3,000
CONTACT: Matthew Smith
         Head of Investor Relations
         Amdocs
         314-212-8328
         E-mail: dox_info@amdocs.com

http://media.globenewswire.com/cache/34518/small/31861.jpg

http://www.globenewswire.com/newsroom/ti?nf=MTMjMTAxNTU4NDgjMzQ1MTg=



Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2017 StockSelector.com. All rights reserved.